Published: 14 January 2016
Author(s): Anca Zimmermann, Christina Zobeley, M.M. Weber, H. Lang, Peter R. Galle, Tim Zimmermann
Issue: January 2016
Section: Original Article

Cardiovascular disease is a leading cause of long-term mortality after liver transplantation (LT). Life long immunosuppression harbors the risk of metabolic alterations. We aimed to analyze the impact of calcineurin (CNI)-only containing regimen (group A) compared to mTOR-containing regimen (group B) on lipid and carbohydrate metabolism.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.